Improved pharmacodynamics and pharmacokinetics after i.v. application of peginterferon alfa‐2a in hepatitis C null responders

Publisher： John Wiley & Sons Inc

E-ISSN： 1478-3231|35|10|2275-2284

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.35, Iss.10, 2015-10, pp. : 2275-2284

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Improved pharmacodynamics and pharmacokinetics after i.v. application of peginterferon alfa‐2a in hepatitis C null responders

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 1478-3223, Iss. 10, 2015-10 ,pp. : 2275-2284

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost-effectiveness of peginterferon alfa-2b in combination with ribavirin as initial treatment for chronic hepatitis C in Sweden

By Bernfort Lars   Sennfält Karin   Reichard Olle  

Scandinavian Journal of Infectious Diseases, Vol. 38, Iss. 6-7, 2006-07 ,pp. : 497-505

Informa Healthcare

Access to resources Recommend Favorite

Prevention of hepatitis C‐related HCC

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 2, 2015-02 ,pp. : 321-328

John Wiley & Sons Inc

Access to resources Recommend Favorite

Extending Combination Therapy with Peginterferon plus Ribavirin for Genotype 2 Chronic Hepatitis C Virological Responders: A Pilot Study of 7 Cases

By  

Intervirology, Vol. 53, Iss. 3, 2010-03 ,pp. : 188-192

Karger

Access to resources Recommend Favorite

On‐treatment prediction of sustained response to peginterferon alfa‐2a for HBeAg‐negative chronic hepatitis B patients

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 5, 2015-05 ,pp. : 1540-1548

John Wiley & Sons Inc

Access to resources Recommend Favorite